HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
RMTI
Rockwell Medical, Inc.
RMTI lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
RMTI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Strong |
RMTI's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
RMTI PE Valuation
RMTI has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
RMTI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Stable | |
| Limited | |
| High |
RMTI has the edge over HIMS on the outlook, with more favorable earnings expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
RMTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.43 | +$0.17 |
| Q2 2026 | -$1.34 | -$0.64 |
| Q1 2026 | -$1.50 | -$1.40 |
| Q4 2025 | -$1.50 | -$1.20 |
| Q3 2025 | -$1.60 | -$1.16 |
| Q2 2025 | -$0.70 | +$0.84 |
| Q1 2025 | -$0.10 | +$3.34 |
| Q4 2024 | -$0.30 | +$3.54 |
RMTI is still losing money, but far less than before: $1.43 per share over the past year, against $61.60 at its worst in late 2019.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over RMTI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over RMTI on profitability, with a higher operating margin.
RMTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.1M | +20% |
| Q2 2026 | $17.8M | +11% |
| Q1 2026 | $17.3M | -8.3% |
| Q4 2025 | $18.3M | -26% |
| Q3 2025 | $15.9M | -44% |
| Q2 2025 | $16.1M | -38% |
| Q1 2025 | $18.9M | -17% |
| Q4 2024 | $24.7M | +12% |
RMTI's revenue is recovering but still below its 2024 peak: $19M last quarter, up 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -1.7 points |
| Q2 2026 | -6% | +2.4 points |
| Q1 2026 | -8.5% | -1.3 points |
| Q4 2025 | -2.2% | -0.1 points |
| Q3 2025 | -10% | -17 points |
| Q2 2025 | -8.4% | -10 points |
| Q1 2025 | -7.2% | -1.4 points |
| Q4 2024 | -2.1% | +0.4 points |
RMTI's operating margin was −12% last quarter, down 1.7 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over RMTI on cash flow, with more consistent year-over-year improvement.
RMTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.2M | -$712K |
| Q2 2026 | $1.5M | -13% |
| Q1 2026 | -$592K | +$3M |
| Q4 2025 | $2.2M | +369% |
| Q2 2025 | $1.7M | +17% |
| Q1 2025 | -$3.6M | -$1.2M |
| Q4 2024 | $470K | +$513K |
| Q2 2024 | $1.4M | +$3.2M |
RMTI's free cash flow has turned positive after six years mostly in the red: $828,000 over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over RMTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
RMTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +13.4K shares |
| 1 year | +10% | +369K shares |
| 3 years | +115% | +2.1M shares |
| 5 years | +367% | +3.1M shares |
| Available history | +617% | +3.4M shares |
RMTI has 4M diluted shares, up 10% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
RMTI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -4.3x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -2.6x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
RMTI has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
RMTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.4 | Neutral |
| Stochastic | 34.5 | Neutral |
RMTI's weekly RSI is 46 (neutral) and its Stochastic is 34 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
RMTI PE vs Healthcare Sector
RMTI has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
RMTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.68 | 3.9% below |
| 20 week MA | $7.37 | 0.1% above |
| 50 week MA | $8.25 | 11% below |
| 100 week MA | $10.8 | 32% below |
| 200 week MA | $17.0 | 57% below |
RMTI has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
RMTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $258.5 | $111.1 | -57% |
| 2021 | $111.1 | $44.0 | -60% |
| 2022 | $44.0 | $9.70 | -78% |
| 2023 | $9.70 | $18.9 | +95% |
| 2024 | $18.9 | $21.4 | +13% |
| 2025 | $21.4 | $8.65 | -60% |
| 2026 YTD | $8.65 | $7.38 | -15% |
RMTI has the edge over HIMS on returns for 2026, with the stronger performance.